← Back to all trials
Recruiting
NCT05618470
Wumeiwan Jiawei Fang Use in Patients With Blepharospasm
Conditions: Dry Eye Syndromes, Meige Syndrome, Blepharospasm, Hyperactivity
Sex: All
Ages: 18 Years – 80 Years
Phase: PHASE2, PHASE3
Enrollment: 80
Sponsor: China Academy of Chinese Medical Sciences
Location: China
Summary
To evaluate the efficacy and safety of Jing Fang Wu Mei Wan Jiawei Fang in the treatment of idiopathic blepharospasm using a clinical randomized controlled trial method.
Eligibility Criteria
Inclusion Criteria:Idiopathic blepharospasm met the diagnostic criteria.The age ranges from 18 to 80 years.Liver Yang deficiency,mixed syndrome of cold and heat.Signed Informed consentExclusion Criteria:Secondary blepharospasm due to keratoconjunctivitis, trichiasis, and blepharitis.Open eyelid disuse.hemifacial spasm.The patient had undergone eye surgery in the previous 6 months.Allergic to the ingredients in the medicine.Corneal lenses were worn during the study.A woman who is pregnant or breastfeeding.Combined with cardiovascular, cerebrovascular,Liver and kidney function, hematopoietic system serious primary disease, mental patients, combined with stroke patients.At the same time, use drugs that interfere with the evaluation of drug efficacy.Idiopathic blepharospasm is treated with other drugs.
Source: ClinicalTrials.gov (NCT05618470). StuddyBuddy aggregates publicly available trial information.
